US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

Something Comically Bad Just Happened to the Inventor of Ozempic

Novo Nordisk, the Danish company behind Ozempic and Wegovy, made one very dumb decision a few years ago that's now poised to massively eat into its profits — a wild twist in the pharma company's saga, and an all-time cautionary tale for its peers. When watching an interview with the head of generic drugmaker Sandoz, Science magazine columnist Derek Lowe learned something incredible: that Novo failed to renew its Canadian patent on semaglutide, t…

US judge upholds FDA’s removal of Ozempic, Wegovy from drug shortage list

US judge upholds FDA’s removal of Ozempic, Wegovy from drug shortage list

US Judge Upholds FDA's Removal of Ozempic, Wegovy From Drug Shortage List

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's blockbuster weight-loss drugs Ozempic and Wegovy, upholding the U.S. Food and Drug Administration's decision to remove the drugs' active ingredient from the shortage list.

FDA’s removal of Ozempic, Wegovy from drug shortage list upheld

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was lawful and that the agency acted correctly. U.S. District Court Judge Mark Pittman found that the Outsourcing Facilities Association (OFA), an organization…

U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

The ruling is a blow to compounding pharmacies that were allowed to produce doses of copies of obesity drugs while the FDA said there was a shortage.